Dae Hyun Ha 1 , Hyun-keun Kim 1 , Joon Lee 2 , Hyuck Hoon Kwon 3 , Gyeong-Hun Park 4 , Steve Hoseong Yang 5 , Jae Yoon Jung 6 , Hosung Choi 7 , Jun Ho Lee 1 , Sumi Sung 1 , Yong Weon Yi 1 , * , Byong Seung Cho 1 , *
07 May 2020
Exosomes are nano-sized vesicles that serve as mediators for cell-to-cell communication. With their unique nucleic acids, proteins, and lipids cargo compositions that reflect the characteristics of producer cells, exosomes can be utilized as cell-free therapeutics. Among exosomes derived from various cellular origins, mesenchymal stem cell-derived exosomes (MSC-exosomes) have gained great attention due to their immunomodulatory and regenerative functions. Indeed, many studies have shown anti-inflammatory, anti-aging and wound healing effects of MSC-exosomes in various in vitro and in vivo models. In addition, recent advances in the field of exosome biology have enabled development of specific guidelines and quality control methods, which will ultimately lead to clinical application of exosomes. This review highlights recent studies that investigate therapeutic potential of MSC-exosomes and relevant mode of actions for skin diseases, as well as quality control measures required for development of exosome-derived therapeutics.